Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Trivitron's Finnish Dx buy underscores trend of emerging players going global?

This article was originally published in Clinica

Executive Summary

Indian medtech firm Trivitron Healthcare has become the latest emerging market player to expand outside its domestic market, acquiring Finnish in vitro diagnostics specialist Ani Labsystems for €15.8 million ($20.6 million), according to media reports. As well as bolstering its diagnostic offering, the deal also gives Trivitron access to a global manufacturing facility.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst